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Objectives: Both short stature and adiposity are risk factors for gestational diabetes mellitus
(GDM). The aim of this study was to simultaneously evaluate the importance of stature and
degree of adiposity on development of GDM in primiparous women.
Study design: Longitudinal cohort study.
Methods: In the city of Vantaa, Finland, between 2009 and 2015, all together 7750 primip-
arous women without previously diagnosed diabetes mellitus gave birth. Of these, 5223
women were 18 years of age with information on height, weight, and complete data from
a 75 g 2-h oral glucose tolerance test composing the study participants of this study.
Results: A 155-cm tall woman with a body mass index (BMI) of 25.5 kg/m2 had a similar risk
for GDM as a 175-cm tall woman with a BMI of 27.1 kg/m2. Women shorter than 159 cm had
the highest prevalence of GDM, 28.7%, whereas women with height between 164 and
167 cm had the lowest prevalence of GDM, 19.9% (P < 0.001). Height was inversely and
significantly associated with both 1- and 2-h glucose values (both P < 0.001).
Conclusions: To avoid over diagnosis of GDM, an unbiased strategy is needed to determine
and diagnose GDM in women with different stature and degree of adiposity.
© 2017 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.d Primary Health Care, University of Helsinki, PO 20, 00014 Helsinki, Finland. Fax: þ358
(M.K. Laine).
ic Health. Published by Elsevier Ltd. All rights reserved.
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Gestational diabetes mellitus (GDM) is a common pregnancy
complication defined as glucose intolerance with onset or first
recognition during pregnancy.1,2 Today, the prevalence of GDM
is estimated to be about 6% in Europe and 9% in North Amer-
ica.3 GDM is associated with adverse short- and long-term
health outcomes for both women and their offspring.4e6 Usu-
ally, the diagnosis of GDM is based upon an oral 2- or 3-h
glucose tolerance test with 75- or 100-g glucose load.1,7,8
It has previously been reported that women with GDM are
at higher childbearing age, more obese, and have a shorter
stature than women without GDM.1,4,9e16 Studies focusing on
the influence of maternal height on fasting and postprandial
glucose levels in pregnant women in relation to the risk of
GDM are limited. Among Brazilian and Korean women, short
stature has been shown to be associated with elevated post-
prandial glucose levels but not with fasting glucose concen-
trations.10,12 With regard to obesity, it is important to keep in
mind that within different ethnic populations, a body mass
index (BMI) may not correspond to the same degree of
adiposity due, in part, to different body composition and thus
different definition criteria for obesity have been suggested;
e.g., for European populations BMI  30 kg/m2 and for Asian
populations BMI  27.5 kg/m2.17,18
In the year 2016, we initiated a long-term follow-up study
in the city of Vantaa, Finland, to evaluate the long-term con-
sequences of gestational glucose intolerance on women's and
their offspring's health. The aim of this study was to evaluate
in primiparous women the association between height,He
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Fig. 1 e Distribution of height and percentage of primiparous w
were: I < 159 cm, II¼ 159e163 cm, III¼ 164e167 cm, IV¼ 168e17degree of adiposity, and the development of GDM based on a
standard 75 g 2-h oral glucose tolerance test (2-h OGTT).Methods
This study is a longitudinal cohort study in the city of Vantaa,
the fourth largest city in Finland. Between January 1, 2009, and
December 31, 2015, in total, 7750 women without previously
diagnosed diabetesmellitus delivered their first child. Of these
primiparous women, 5223 women aged 18 years or more had
height and weight data and complete data from a 75 g 2-h
OGTT and formed the study cohort. According to the Finnish
Current Care Guidelines for GDM, GDM should be screened
using 2-h OGTT in all pregnant women, except those who are
at low risk, e.g. primiparous womenwith BMI 18.5e24.9 kg/m2
without first-degree family history of diabetes.19
Data on deliveries were obtained from the Finnish Medical
Birth Register, kept by the National Institute for Health and
Welfare, Finland, which collects the information from the de-
livery hospitals. The quality of the Finnish Medical Birth Reg-
ister has been found to be good.20 The following information
was obtained from this register: participants' pregestational
height, weight, previous pregnancies (miscarriages, induced
abortions, or ectopic pregnancies) and deliveries, infertility
treatment, GDM, and smoking during pregnancy.21 BMI was
calculated as body weight (kg) divided by height2 (m2) (kg/m2).
Educational attainment was defined according to the
number of years of schooling and obtained from Statistics
Finland.22ight, cm
0 165 170 175 180 185 190
II III IV V
omen with and without GDM according to height. Cutoffs
2 cm, and V > 172 cm. GDM¼ gestational diabetes mellitus.
Table 1 e Characteristics of the study participants (N ¼ 5223) according to height categories.
Height category P-valuea
I [N ¼ 689] II [N ¼ 1277] III [N ¼ 1221] IV [N ¼ 1343] V [N ¼ 693]
Height (cm), mean (range) 155 (135e158) 161 (159e163) 165 (164e167) 170 (168e172) 176 (173e190)
Age (years), mean (SD) 28$9 (4$9) 29$2 (4$8) 29$4 (4$8) 29$5 (4$8) 29$9 (4$7) <0.001
Cohabiting, n (%) 565 (82) 1049 (82) 1004 (82) 1105 (82) 586 (85) 0.28
Smokers,b n (%) 97 (14) 189 (15) 179 (15) 202 (15) 94 (14) 0.90
Weight (kg), mean (SD) 59$0 (11$6) 63$4 (11$3) 67$1 (13$0) 71$2 (14$3) 75$5 (15$7) <0.001
BMI (kg/m2), mean (SD) 24$4 (4$7) 24$4 (4$3) 24$5 (4$7) 24$7 (5$0) 24$5 (4$9) 0.32
Years of schooling, mean (SD) 12$9 (2$8) 13$4 (2$7) 13$6 (2$6) 13$7 (2$7) 13$9 (2$7) <0.001
Previous pregnancies, n (%) 149 (22) 258 (20) 242 (20) 291 (22) 112 (16) 0.12
Infertility treatments, n (%) 48 (7) 112 (9) 118 (10) 149 (11) 74 (11) 0.002
Number of fetuses 2 7 (1) 20 (2) 18 (1) 12 (1) 10 (1) 0.77
BMI ¼ body mass index; SD ¼ standard deviation.
a P-value for linearity.
b Including those who quitted during pregnancy.
p u b l i c h e a l t h 1 5 6 ( 2 0 1 8 ) 1 0 1e1 0 8 103GDM was defined as one or more pathological glucose
values in a 75 g 2-h OGTT with the following diagnostic
thresholds: fasting plasma glucose 5.3 mmol/L, 1-h glucose
10.0 mmol/L, and 2-h glucose 8.6 mmol/L.19
Statistical analysis
Data are presented as means with range or standard de-
viations (SD) or as counts with percentages. Standardized
values were divided into five height level categories using z-
values: I (<1.5), II (1.5 to <0.319), III (0.319 to <0.319), IVHeight level
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Fig. 2 e Prevalence of and estimated risk for GDM among primip
prevalence of GDM in five height categories, adjusted for age, y
pregnancies. The right panel shows the estimated risk for GDM
(average height in the study cohort), adjusted for age, years of ed
odds ratios were derived from a 5-knot restricted cubic splines
II¼ 159e163 cm, III¼ 164e167 cm, IV¼ 168e172 cm, and V > 17
mellitus; OR ¼ odds ratio.(0.319 to <1.15), and V (1.15) corresponding to grades con-
taining 12.5%, 25%, 25%, 25%, and 12.5% of the total distribu-
tion. Statistical significance for the hypothesis was evaluated
by using generalized linearmodels (e.g. analysis of variance or
regression models) with appropriate distribution and link
function. In the case of violation of the assumptions (e.g.
normality), a bootstrap type test was used. A possible non-
linear relationship between GDM or 2-h OGTT and the
height was assessed by using 5-knot restricted cubic spline
regression or quadraticmodels. The normality of the variables
was tested by using the ShapiroeWilk test. The time-weightedHeight, cm
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p u b l i c h e a l t h 1 5 6 ( 2 0 1 8 ) 1 0 1e1 0 8104area under the curve (AUC) for plasma glucose during the
OGTT was determined by the trapezoidal method. Stata 14.1
(StataCorp LP; College Station, Texas, USA) statistical package
was used for the analysis.Height, cm
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Fig. 3 e Relationship between height and AUC (2-h OGTT)
in primiparous women with and without GDM (both
P < 0·001). The models were including quadratic terms for
AUC and adjusted for age, years for education,
prepregnancy BMI, and previous pregnancies. AUC¼ time-
weighted area under the curve; GDM ¼ gestational
diabetes mellitus; 2-h OGGT ¼ a 2-h 75-g oral glucose
tolerance test.Results
Characteristics of the study participants according to height
categories
A histogram showing height in the primiparous women with
and without GDM is shown in Fig. 1; the mean height of the
study participants was 165.5 (6.3) cm. Table 1 presents char-
acteristics of the women according to five height categories;
the cutoffs were: I < 159 cm, II¼ 159e163 cm, III¼ 164e167 cm,
IV ¼ 168e172 cm, and V > 172 cm. Height was positively
associated with age, educational attainment, and infertility
treatments (P < 0.001). In relation to the study participants'
prepregnancy BMI, no statistically significant differences were
observed between the height categories (P ¼ 0.32).
Height and GDM
Fig. 2 shows the prevalence of GDM in different height cate-
gories, adjusted for age, years of education, prepregnancy BMI,
and previous pregnancies. The women in the lowest height
category (<159 cm) had the highest prevalence of GDM, 28.7%,
whereas the women in the height category 164e167 cm had
the lowest prevalence of GDM, 19.9% (P < 0.001), similar to the
prevalence in the two highest height categories. Among
womenwhowere 155 cm tall, the odds ratio (OR) for GDMwas
1.49 (95% CI: 1.21e1.83) compared with 165-cm tall women
after adjustment for age, years of education, prepregnancy
BMI, and previous pregnancies (Fig. 2).
Height was inversely associated with 1- and 2-h glucose
concentrations (both P < 0.001) and glucose AUC (P < 0.001)
during the OGTT (Table 2). Glucose AUC was inversely asso-
ciatedwith height amongwomenwithout GDMandwith GDM
(both P < 0.001) (Fig. 3).
Height, prepregnancy BMI, and GDM
Short primiparous women with prepregnancy BMI <25 kg/m2
had a high risk for GDM (Fig. 4); 155-cm tall women had an ORTable 2 e Glucose concentrations during a 2-h 75 g OGTT and
women.
He
I [N ¼ 689] II [N ¼ 1277] III
2-h OGTT
0-h mmol/L, mean (SD) 4.81 (0.45) 4.77 (0.40)
1-h mmol/L, mean (SD) 7.93 (1.87) 7.59 (1.77)
2-h mmol/L, mean (SD) 6.84 (1.58) 6.54 (1.46)
AUC 6.88 (1.30) 6.62 (1.20)
AUC ¼ time-weighted area under the curve; 2-h OGGT ¼ 2-h 75-g oral glu
a P-value for linearity adjusted for age, years of education, prepregnancy
egories were: I < 159 cm, II ¼ 159e163 cm, III ¼ 164e167 cm, IV ¼ 168eof 1.54 (95% CI: 1.16e2.04) compared with women 165 cm tall
(adjusted for age, years of education, and previous pregnan-
cies). Among women with prepregnancy BMI between 25.0
and 29.9 kg/m2, 155-cm tall women had an OR 1.57 (95% CI:
1.04e2.38) compared with 165-cm tall women. TheAUC in different height categories among primiparous
ight category P-valuea
[N ¼ 1221] IV [N ¼ 1343] V [N ¼ 693]
4.77 (0.41) 4.78 (0$42) 4.81 (0.38) 0.60
7.54 (1.74) 7.39 (1.75) 7.24 (1.72) <0.001
6.46 (1.43) 6.29 (1.43) 5.96 (1.37) <0.001
6.58 (1.19) 6.46 (1.20) 6.31 (1.14) <0.001
cose tolerance test; SD ¼ standard deviation.
body mass index, and previous pregnancies. Cutoffs for height cat-
172 cm, and V > 172 cm.
Fig. 4 e Prevalence of GDM and risk for GDM among primiparous women in different prepregnancy BMI categories according
to height. The upper panel shows age-adjusted prevalence of GDM among primiparous women in different prepregnancy
BMI categories by height. The lower panel shows age-adjusted odds ratios for GDM among primiparous women in different
prepregnancy BMI categories according to height compared with primiparous womenwith 165 cm height (average height in
the study cohort). The models were derived from a 5-knot restricted cubic splines model and adjusted for age, years for
education, and previous pregnancies. BMI ¼ body mass index; GDM ¼ gestational diabetes mellitus; OR ¼ odds ratio.
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p u b l i c h e a l t h 1 5 6 ( 2 0 1 8 ) 1 0 1e1 0 8106corresponding values for 175-cm tall women were OR 1.55
(95% CI: 1.02e2.35) compared with 165-cm tall women (both
adjusted for age, years of education, and previous pregnan-
cies). Fig. 4 shows the prevalence (adjusted for age and pre-
vious pregnancies) of GDM among primiparous women in
different BMI categories according to height.
GDM was diagnosed at a lower degree of adiposity in
women of short stature. Fig. 5 illustrates that 155-cm tall
women and with a mean BMI of 25.5 kg/m2 had a similar risk
for GDM as women with BMI of 26.4 kg/m2 and who were
165 cm tall and women with BMI of 27.1 kg/m2 who were
175 cm (all adjusted for age).Discussion
According to our observations, GDMwas diagnosed at a lower
degree of adiposity in short primiparous women compared
with primiparous women of taller stature. Primiparous
women in the lowest height quintile (<159 cm) had a preva-
lence of GDM of 28.7%. Furthermore, short stature was asso-
ciated with higher postprandial glucose concentrations but
not with fasting glucose concentrations.
Also normal weight primiparous women (BMI < 25.0 kg/m2)
with short stature had an elevated risk for GDM, whereas in
women at average or tall stature, no such association was
observed. In primiparous women with BMI 25.0e29.9 kg/m2,
the association between height and GDM seemed to beHeight, cm
140 150 160 170 180
BM
I
20
21
22
23
24
25
26
27
28
29
30
31
32
With GDM
Without GDM
Fig. 5 e Relationship between height, prepregnancy BMI, and G
prepregnancy BMI in primiparous women at different height wi
the differences in mean prepregnancy BMI among primiparous
for age. The dashed line refers to women without GDM. BMI ¼U-shaped. Among obese primiparous women again, height
showed no association with GDM. To the best of our knowl-
edge, this is the first study to simultaneously assess the as-
sociation between height, degree of adiposity, and the
development of GDM in primiparous women.
Our study findings show that primiparous women with
short stature had elevated risk for GDM. This observation is
consistent with the previous findings including both pri-
miparous and multiparous women.9e12,14e16 According to
our findings, primiparous women's short stature was asso-
ciated with higher postprandial glucose concentrations but
not with fasting glucose concentrations. These observations
endorse the previous findings in primiparous and multipa-
rous Brazilian and Korean women.10,12 On the whole,
previous data on the association between height and GDM
in primiparous women are very limited; most previous
studies have pooled primiparous and multiparous
women.9e12,15,16,23
In the present study, primiparous women with tall stature
were significantly older than women with short stature. One
explanatory factor can be educational attainment; tall pri-
miparouswomen had higher educational attainment.Women
with low educational attainment have high incidence of GDM,
which is mainly due to higher rates of adiposity.24,25
GDM is a multifactorial disease, and several factors affect
the development of GDM including insulin resistance, inade-
quate insulin secretion from pancreatic b-cells, genetic sus-
ceptibility, and a sedentary lifestyle.26,27 Usually, insulinHeight, cm
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p u b l i c h e a l t h 1 5 6 ( 2 0 1 8 ) 1 0 1e1 0 8 107resistance increases with the insulin-desensitizing effects of
the hormonal products of the placenta andwith an increase in
maternal adiposity.26 Height also plays an important role. It is
widely known that muscle tissue is the major tissue involved
in glucose uptake and people with short stature have less
muscle massealthough not necessarily a lower percentage of
muscle tissue relative to total body massethan taller peo-
ple.28e31 Furthermore, a recently published study among non-
pregnant people showed that height showed a positive asso-
ciation with b-cell function and insulin sensitivity.31 In addi-
tion, the ability to absorb andmetabolize glucose in a standard
OGTT seems to differ according to stature of the individual;
individuals with short stature and with low fat-free mass
absorb glucose slower, which is seen in a standard OGTT as
high postprandial glycemic levels.30,32 Our study findings
endorse these observations.
The following are the strengths of our study. Our study
cohort is comprehensive; all primiparous women from the
city of Vantaa, the fourth largest city in Finland, over a seven-
year time period are included. The diagnosis of GDM was
based on a 75 g standard 2-h oral glucose tolerance test. Health
care professionals measured height and it was not based on
self-reports. In addition, the quality of Finnish register data is
high.20
Our study has limitations. We did not have any informa-
tion on family history of diabetes, body composition, gesta-
tional weight gain, physical activity, diet, or sleeping patterns.
Furthermore, because almost 95% of the study population had
European background and less than 4% had Asian back-
ground, the study findings cannot be generalized.
In conclusion, there seems to be a risk that women with
short stature are diagnosed to have GDM because of applica-
tion of a standard glucose load. Further studies are needed to
find out an unbiased way to diagnose GDM in women of
different stature and with different BMI.Author statements
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